Spyre Therapeutics, Inc. (SYRE) — 10-K/A Filings
All 10-K/A filings from Spyre Therapeutics, Inc.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (2)
-
Spyre Therapeutics Files 2023 10-K Amendment
— Nov 18, 2024 Risk: medium
Spyre Therapeutics, Inc. filed an amendment to its 2023 10-K on November 18, 2024, detailing its financial performance for the fiscal year ending December 31, 2 -
Spyre Therapeutics Files 10-K/A Amendment for Fiscal Year 2023
— Mar 1, 2024 Risk: low
Spyre Therapeutics, Inc. (SYRE) filed a Amended Annual Report (10-K/A) with the SEC on March 1, 2024. Spyre Therapeutics, Inc. filed an amendment (10-K/A) to it
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX